• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环游离DNA作为可切除壶腹癌的预后生物标志物

Circulating Cell-Free DNA as a Prognostic Biomarker in Resectable Ampullary Cancer.

作者信息

Shyr Bor-Uei, Shyr Bor-Shiuan, Chen Shih-Chin, Chang Shih-Ching, Shyr Yi-Ming, Wang Shin-E

机构信息

Department of Surgery, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan.

Department of Surgery, Taipei Veterans General Hospital, Taipei 11217, Taiwan.

出版信息

Cancers (Basel). 2021 May 12;13(10):2313. doi: 10.3390/cancers13102313.

DOI:10.3390/cancers13102313
PMID:34065893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8151754/
Abstract

Circulating cell-free DNA (cfDNA) in ampullary cancer patients was measured to clarify the correlation between cfDNA and clinicopathological factors and the impact of cfDNA on survival outcomes. Patients with ampullary cancer undergoing pancreaticoduodenectomy were included. Correlations between cfDNA and clinicopathological and prognostic factors were determined. The cfDNA levels in patients ranged from 1282 to 21,674 copies/mL, with a median of 6687 copies/mL. The cfDNA level was significantly higher in patients with lymph node involvement, lymphovascular invasion, abnormal serum carcinoembryonic antigen (CEA) level, and stage II and III cancer. Poor prognostic factors for ampullary cancer included high cfDNA > 6687 copies/mL, lymph node involvement, abnormal serum CEA > 5 ng/mL, and advanced stage II and III cancer. The 1- and 5-year survival rates were 92.0% and 66.5%, respectively, for patients with low cfDNA < 6687 copies/mL and 84.0% and 49.9%, respectively, for patients with high cfDNA > 6687 copies/mL ( < 0.001). After multivariate analysis, only the cfDNA level and stage were independent prognostic factors of ampullary cancer. Thus, the cfDNA level could act as a surrogate marker of both disease extent and biological aggressiveness of ampullary cancer. Moreover, cfDNA plays a significant role in the prognosis of resectable ampullary cancer.

摘要

测量壶腹癌患者循环游离DNA(cfDNA)水平,以阐明cfDNA与临床病理因素之间的相关性以及cfDNA对生存结局的影响。纳入接受胰十二指肠切除术的壶腹癌患者。确定cfDNA与临床病理及预后因素之间的相关性。患者的cfDNA水平在1282至21674拷贝/毫升之间,中位数为6687拷贝/毫升。在有淋巴结转移、淋巴管浸润、血清癌胚抗原(CEA)水平异常以及II期和III期癌症患者中,cfDNA水平显著更高。壶腹癌的不良预后因素包括cfDNA>6687拷贝/毫升、淋巴结转移、血清CEA>5 ng/mL以及II期和III期晚期癌症。cfDNA<6687拷贝/毫升的患者1年和5年生存率分别为92.0%和66.5%,cfDNA>6687拷贝/毫升的患者分别为84.0%和49.9%(<0.001)。多因素分析后,只有cfDNA水平和分期是壶腹癌的独立预后因素。因此,cfDNA水平可作为壶腹癌疾病范围和生物学侵袭性的替代标志物。此外,cfDNA在可切除壶腹癌的预后中起重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7967/8151754/9eef01e4b84b/cancers-13-02313-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7967/8151754/d6471975c3c6/cancers-13-02313-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7967/8151754/016f251ed1c2/cancers-13-02313-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7967/8151754/9eef01e4b84b/cancers-13-02313-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7967/8151754/d6471975c3c6/cancers-13-02313-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7967/8151754/016f251ed1c2/cancers-13-02313-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7967/8151754/9eef01e4b84b/cancers-13-02313-g003.jpg

相似文献

1
Circulating Cell-Free DNA as a Prognostic Biomarker in Resectable Ampullary Cancer.循环游离DNA作为可切除壶腹癌的预后生物标志物
Cancers (Basel). 2021 May 12;13(10):2313. doi: 10.3390/cancers13102313.
2
Cell-free DNA as a prognostic and predictive biomarker in resectable distal common bile duct cancer.游离 DNA 作为可切除的远端胆总管癌的预后和预测生物标志物。
J Chin Med Assoc. 2023 Sep 1;86(9):835-841. doi: 10.1097/JCMA.0000000000000923. Epub 2023 Mar 31.
3
Circulating Cell-Free DNA in Pancreatic Head Adenocarcinoma Undergoing Pancreaticoduodenectomy.胰头腺癌行胰十二指肠切除术后循环游离 DNA 检测。
Pancreas. 2021 Feb 1;50(2):214-218. doi: 10.1097/MPA.0000000000001730.
4
Circulating Cell-Free DNA Levels Could Predict Oncological Outcomes of Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma.循环游离DNA水平可预测接受食管鳞状细胞癌食管切除术患者的肿瘤学结局。
Int J Mol Sci. 2016 Dec 17;17(12):2131. doi: 10.3390/ijms17122131.
5
The emerging role of cell-free DNA as a molecular marker for duodenal adenocarcinoma.游离DNA作为十二指肠腺癌分子标志物的新作用。
J Chin Med Assoc. 2024 Apr 1;87(4):422-427. doi: 10.1097/JCMA.0000000000001079. Epub 2024 Feb 23.
6
Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.根治性切除治疗 Vater 壶腹癌的病理亚型的临床意义。
J Surg Oncol. 2012 Mar;105(3):266-72. doi: 10.1002/jso.22090. Epub 2011 Aug 31.
7
Serum carcinoembryonic antigen as a prognostic factor in resectable gastric cancer.血清癌胚抗原作为可切除胃癌的预后因素
J Am Coll Surg. 1998 Jul;187(1):64-8. doi: 10.1016/s1072-7515(98)00133-1.
8
Clinical implications of circulating cell-free DNA quantification and metabolic tumor burden in advanced non-small cell lung cancer.循环游离 DNA 定量和代谢肿瘤负荷在晚期非小细胞肺癌中的临床意义。
Lung Cancer. 2019 Aug;134:158-166. doi: 10.1016/j.lungcan.2019.06.014. Epub 2019 Jun 13.
9
The role of lymph nodes in predicting the prognosis of ampullary carcinoma after curative resection.淋巴结在壶腹癌根治性切除术后预后预测中的作用。
World J Surg Oncol. 2015 Jul 25;13:224. doi: 10.1186/s12957-015-0643-1.
10
The Prognostic Impact of the Carcinoembryonic Antigen in Ampullary Cancer - A Retrospective Single Center Study.癌胚抗原在壶腹癌中的预后影响——一项回顾性单中心研究
J Cancer. 2017 Feb 25;8(4):657-664. doi: 10.7150/jca.16200. eCollection 2017.

本文引用的文献

1
Circulating Cell-Free DNA in Pancreatic Head Adenocarcinoma Undergoing Pancreaticoduodenectomy.胰头腺癌行胰十二指肠切除术后循环游离 DNA 检测。
Pancreas. 2021 Feb 1;50(2):214-218. doi: 10.1097/MPA.0000000000001730.
2
Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq).采用甲基化 CpG 串联扩增和测序(MCTA-Seq)对血浆无细胞 DNA 的组织起源进行全面的 DNA 甲基化分析。
Clin Epigenetics. 2019 Jun 24;11(1):93. doi: 10.1186/s13148-019-0689-y.
3
Liver-derived cell-free nucleic acids in plasma: Biology and applications in liquid biopsies.
血浆中肝来源的无细胞核酸:液体活检中的生物学和应用。
J Hepatol. 2019 Aug;71(2):409-421. doi: 10.1016/j.jhep.2019.04.003. Epub 2019 Apr 18.
4
Life and death of circulating cell-free DNA.循环游离 DNA 的生死。
Cancer Biol Ther. 2019;20(8):1057-1067. doi: 10.1080/15384047.2019.1598759. Epub 2019 Apr 16.
5
Ampullary Cancer.壶腹癌。
Surg Clin North Am. 2019 Apr;99(2):357-367. doi: 10.1016/j.suc.2018.12.001. Epub 2019 Feb 10.
6
Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.无细胞游离 DNA 中的表观遗传生物标志物及其在液体活检中的应用。
Genes (Basel). 2019 Jan 9;10(1):32. doi: 10.3390/genes10010032.
7
Application of Cell-free DNA Analysis to Cancer Treatment.游离DNA分析在癌症治疗中的应用。
N Engl J Med. 2018 Nov 1;379(18):1754-1765. doi: 10.1056/NEJMra1706174.
8
Monitoring Tumor Burden in Response to FOLFIRINOX Chemotherapy Via Profiling Circulating Cell-Free DNA in Pancreatic Cancer.通过分析胰腺癌患者循环游离 DNA 监测 FOLFIRINOX 化疗的肿瘤负荷。
Mol Cancer Ther. 2019 Jan;18(1):196-203. doi: 10.1158/1535-7163.MCT-17-1298. Epub 2018 Oct 9.
9
The Significance of Liquid Biopsy in Pancreatic Cancer.液体活检在胰腺癌中的意义
J Cancer. 2018 Sep 8;9(18):3417-3426. doi: 10.7150/jca.24591. eCollection 2018.
10
Comparison between robotic and open pancreaticoduodenectomy with modified Blumgart pancreaticojejunostomy: A propensity score-matched study.机器人与开腹胰十二指肠切除术联合改良 Blumgart 胰肠吻合术的比较:一项倾向评分匹配研究。
Surgery. 2018 Dec;164(6):1162-1167. doi: 10.1016/j.surg.2018.06.031. Epub 2018 Aug 6.